XML 34 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies and Concentrations of Risk (Tables)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Summary of Revenues
The Company recorded the following revenues for the three and nine months ended September 30, 2023 and 2022:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Product sales, net$85,288 $75,213 $233,957 $189,647 
Collaborative and other revenues1,454 614 4,054 1,635 
Total revenues$86,742 $75,827 $238,011 $191,282 
The Company recorded the following revenues (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
ORLADEYO:
U.S.$75,268 $60,106 $208,934 $162,743 
Outside of U.S.10,416 5,866 26,173 18,155 
Total ORLADEYO85,684 65,972 235,107 180,898 
Other revenues1,058 9,855 2,904 10,384 
Total revenues$86,742 $75,827 $238,011 $191,282 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share The Company excluded the following potential common shares, presented based on amounts outstanding as of September 30, 2023 and September 30, 2022, from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:
September 30, 2023September 30, 2022
Outstanding stock options35,160 32,647 
Unvested restricted stock unit awards4,589 2,760 
Warrants to purchase common stock15,023 15,023 
Total54,772 50,430